Reduced Expression of PER3 Is Associated with Incidence and Development of Colon Cancer
Authors:
- 17 February 2012
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 19 (9) , 3081-3088
Abstract
Period 3 (PER3), a circadian regulation protein, influences cell cycle, growth, and differentiation. The aim of the present study was to determine whether PER3 expression is associated with colon cancer incidence and progression. PER3 expression was analyzed in the normal and cancerous tissues from patients with colon cancer by establishing a long serial analysis of gene expression (SAGE) database as well as by real-time PCR and immunohistochemistry. As compared with normal tissue, a 2.8-fold decrease in PER3 mRNA levels in colon cancerous tissue was observed. Real-time PCR analysis revealed that PER3 mRNA levels in tumor tissues were lower than in normal tissues (P < 0.001) in both patients with colon tumor and those with rectal tumor. In addition, PER3 expression was related to multiple clinicopathologic factors, including tumor location, differentiation, and stage. Furthermore, the incidence of death was higher in subjects with PER3-negative tumors (P = 0.025); the estimated overall survival time was 71.5 ± 2.2 months and 58.6 ± 5.0 months in subjects with PER3-positive and PER3-negative tumors, respectively (P = 0.020). PER3 may play a role in colon cancer progression.Keywords
This publication has 24 references indexed in Scilit:
- Per3, a circadian gene, is required for Chk2 activation in human cellsFEBS Letters, 2010
- Colon cancerCritical Reviews in Oncology/Hematology, 2010
- Testing the Circadian Gene Hypothesis in Prostate Cancer: A Population-Based Case-Control StudyCancer Research, 2009
- Metabolism and cancer: the circadian clock connectionNature Reviews Cancer, 2009
- IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and PathogenesisAnnals of Surgical Oncology, 2009
- Gene‐expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene‐expression analysesCancer, 2008
- Disturbance of circadian gene expression in hepatocellular carcinomaMolecular Carcinogenesis, 2008
- Downregulation of circadian clock genes in chronic myeloid leukemia: Alternative methylation pattern of hPER3Cancer Science, 2006
- Deregulated expression of the PER1 , PER2 and PER3 genes in breast cancersCarcinogenesis, 2005
- Coordination of circadian timing in mammalsNature, 2002